Journal Article

Sex-specific outcomes and left atrial remodeling following catheter ablation of persistent atrial fibrillation: results from the DECAAF II trial

Shamaileh, Ghaith, kmann, Mathias, Lim, Chanho, Bsoul, Mayana, Sommer, Philipp, Mekhael, Mario, Akoum, Nazem, Donnellan, Eoin, Hajjar, Abdel Hadi El, Bidaoui, Ghassan, Feng, Han, Chouman, Nour, Rao, Swati, Sohns, Christian, Tsakiris, Eli, Mahnkopf, Christian, Kreidieh, Omar, Noujeim, Charbel, Dagher, Lilas, Marrouche, Nassir, Younes, Hadi, Assaf, Ala, Pandey, Amitabh C, Polo, Francisco Tirado, Brachmann, Johannes

2024

Overview

BackgroundCatheter ablation is recognized as an effective treatment for atrial fibrillation (AF). Despite its effectiveness, significant sex-specific differences have been observed, which influence the outcomes of the procedure. This study explores these differences in a cohort of patients with persistent AF. We aim to assess sex differences in baseline characteristics, symptoms, quality of life, imaging findings, and response to catheter ablation in patients with persistent AF.MethodsThis post hoc analysis of the DECAAF II trial evaluated 815 patients (161 females, 646 males). Between July 2016 and January 2020, participants were enrolled and randomly assigned to receive either personalized ablation targeting left atrial (LA) fibrosis using DE-MRI in conjunction with pulmonary vein isolation (PVI) or PVI alone. In this analysis, we aimed to compare female and male patients in the full cohort in terms of demographics, risk factors, medications, and outcomes such as AF recurrence, AF burden, LA volume reduction assessed by LGE-MRI before and 3 months after ablation, quality of life assessed by the SF-36 score, and safety outcomes. Statistical methods included t-tests, chi-square, and multivariable Cox regression.ResultsFemales were generally older with more comorbidities and experienced higher rates of arrhythmia recurrence post-ablation (53.3% vs. 40.2%, p < 0.01). Females also showed a higher AF burden (21% vs. 16%, p < 0.01) and a smaller reduction in left atrial volume indexed to body surface area post-ablation compared to male patients (8.36 (9.94) vs 11.35 (13.12), p-value 0.019). Quality of life scores were significantly worse in females both pre- and post-ablation (54 vs. 66 pre-ablation; 69 vs. 81 post-ablation, both p < 0.01), despite similar improvements across sexes. Safety outcomes and procedural parameters were similar between male and female patients.ConclusionThe study highlights significant differences in the outcomes of catheter ablation of persistent AF between sexes, with female patients showing worse quality of life, higher recurrence of AF and AF burden after ablation, and worse LA remodeling.

• Publisher: Springer Nature B.V
• Subject: Ablation / Arrhythmia / Cardiac arrhythmia / Catheters / Chi-square test / Comorbidity / Effectiveness / Females / Fibrillation / Fibrosis / Gender differences / Lung diseases / Magnetic resonance imaging / Males / Medical instruments / Quality of life / Radiofrequency ablation / Risk factors / Sex differences / Sexes / Statistical analysis / Statistical methods